Glaxo Wellcome Professor of Pharmaceutics
University of Texas at Austin
Maria Croyle, Ph.D., is a Professor of Molecular Pharmaceutics and Drug Delivery at the University of Texas at Austin. She has over 25 years of experience in formulation and development of recombinant viruses for immunization and gene therapy with 60 peer reviewed publications and 5 US patents issued or pending in this area. Her team was the first to report long-lasting protection from Ebola after administration of a single dose of the vaccine in non-human primates. Her group also discovered and patented a very novel method for stabilizing and improving the distribution of live vaccines. This technology was licensed to a new startup company, Jurata, in Research Triangle Park, NC in 2019 which she co-founded and serves as the Chief Scientific Officer. Dr. Croyle has served on the USP Biologics and Biotechnology Expert Committee for Cell, Gene and Tissue Therapies. Her laboratory has participated in international studies to characterize an Interleukin-4 standard by the USP and an adenovirus reference standard by the FDA/CBER. Dr. Croyle’s research program trains young scientists to design and effectively conduct studies for pre-clinical evaluation of virus-based vaccines and gene therapy vectors which has prepared them for careers in the biotech industry, academia and regulatory agencies.